Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecuritySEAC / SeaChange International, Inc. (811699107)
IndustryRadio and Television Broadcasting and Communications Equipment
Institutional Owners78
Institutional Shares27,022,381 - 75.86%
Common Shares Outstanding35,621,615 shares (as of 2018-04-30)
Institutional Value$ 4,641,054,000 USD

Institutional Stock Ownership and Shareholders()

SeaChange International, Inc. (NASDAQ:SEAC) has 78 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,022,381 shares. Largest shareholders include Ariel Investments, Llc, Neuberger Berman Group LLC, Dimensional Fund Advisors Lp, Renaissance Technologies LLC, Segall Bryant & Hamill, Llc, Vanguard Group Inc, Royce & Associates LLC, PenderFund Capital Management Ltd., Algert Global Llc, and Alambic Investment Management, L.P..
SeaChange International, Inc. (NASDAQ:SEAC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 17,303 0 -100.00 68 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 1,584,224 2,066,992 30.47 6,226 5,602 -10.02
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 1 0 -100.00 0 0
2018-05-15 13F-HR DSC Advisors, L.P. 0 370,000 0 1,003
2018-05-11 13F-HR SEI INVESTMENTS CO 10,435 11,970 14.71 41 32 -21.95
2018-05-10 13F-HR JP Morgan Chase & Co 2,400 253,888 10,478.67 9 688 7,544.44
2018-05-15 13F-HR BARCLAYS PLC 3,100 2 -99.94 8 0 -100.00
2018-05-15 13F-HR JANE STREET GROUP, LLC 11,032 0 -100.00 43 0 -100.00
2018-05-11 13F-HR Russell Investments Group, Ltd. 37,900 37,900 0.00 150 103 -31.33
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 35 0 -100.00 0 0
2018-05-15 13F-HR UBS Group AG 1,210 320 -73.55 5 1 -80.00
2018-05-08 13F-HR Alambic Investment Management, L.P. 94,739 710,353 649.80 372 1,925 417.47
2018-05-10 13F-HR CONNORS INVESTOR SERVICES INC 619,215 626,228 1.13 2,434 1,697 -30.28
2018-05-15 13F-HR DEUTSCHE BANK AG\ 303,315 383,213 26.34 1,191 1,038 -12.85
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 175,700 180,000 2.45 691 488 -29.38
2018-05-15 13F-HR VIEX Capital Advisors, LLC 2,887,619 0 -100.00 11,348 0 -100.00
2018-05-07 13F-HR PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 30,000 81
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 10,062 11,431 13.61 40 31 -22.50
2018-05-14 13F-HR EAM Investors, LLC 144,255 140,809 -2.39 567 382 -32.63
2017-02-10 13F-HR BlackRock Advisors LLC 7,106 7,106 0.00 21 16 -23.81
2018-05-14 13F-HR RMB Capital Management, LLC 10,100 30,600 202.97 40 83 107.50
2018-04-19 13F-HR Eidelman Virant Capital 156,200 242,000 54.93 613 655 6.85
2018-05-08 13F-HR ClariVest Asset Management LLC 66,197 180
2018-05-15 13F-HR MANAGED ASSET PORTFOLIOS, LLC 40,000 52,800 32.00 157 143 -8.92
2018-05-02 13F-HR ALGERT GLOBAL LLC 775,731 1,043,648 34.54 3,049 2,828 -7.25
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 667,063 667,063 0.00 2,621 1,808 -31.02
2018-05-11 13F-HR PINNACLE ASSOCIATES LTD 31,841 19,400 -39.07 125 53 -57.60
2018-05-14 13F-HR Roumell Asset Management, LLC 644,498 0 -100.00 2,533 0 -100.00
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 698 477 -31.66 3 1 -66.67
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 147,460 400
2018-05-07 13F-HR Engineers Gate Manager LP 16,312 44
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 51,250 12,304 -75.99 127 33 -74.02
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 43,969 95,134 116.37 173 257 48.55
2018-05-01 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 19,500 19,500 0.00 77 53 -31.17
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 19,371 0 -100.00 76 0 -100.00
2018-07-11 13F-HR Vigilant Capital Management, LLC 25,000 25,000 0.00 68 86 26.47
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 329,243 332,979 1.13 1,294 902 -30.29
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 127,708 149,608 17.15 502 405 -19.32
2018-04-27 13F-HR Penbrook Management LLC 40,000 36,500 -8.75 157 99 -36.94
2018-05-15 13F-HR PUTNAM INVESTMENTS LLC 219,200 95,121 -56.61 861 258 -70.03
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 32,044 33,398 4.23 126 91 -27.78
2018-05-09 13F-HR NORTHERN TRUST CORP 108,588 108,949 0.33 427 296 -30.68
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 0 17,732 0 48
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 67,900 65,700 -3.24 267 178 -33.33
2018-05-10 13F-HR Spark Investment Management LLC 84,600 229
2018-05-12 13F-HR Hillsdale Investment Management Inc. 18,200 373,200 1,950.55 72 1,011 1,304.17
2018-05-04 13F-HR PenderFund Capital Management Ltd. 764,793 1,437,584 87.97 2,841 4,572,000 160,829.25
2018-05-11 13F-HR MACQUARIE GROUP LTD 40,404 263,052 551.05 159 713 348.43
2018-05-14 13F-HR Adirondack Research & Management Inc. 167,498 167,498 0.00 658 454 -31.00
2018-04-23 13F-HR CAPROCK Group, Inc. 29,125 32,325 10.99 108 88 -18.52
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 20,196 184,713 814.60 79 501 534.18
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 169,059 208,908 23.57 664 566 -14.76
2018-05-15 13F-HR STATE STREET CORP 42,401 42,401 0.00 167 115 -31.14
2017-02-10 13F-HR BlackRock Fund Advisors 93,124 96,158 3.26 278 221 -20.50
2018-05-15 13F-HR Squarepoint Ops LLC 56,400 70,100 24.29 222 190 -14.41
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 288,803 202,791 -29.78 1,135 550 -51.54
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 19,624 53
2018-05-23 13F-HR/A Allianz Asset Management AG 32,325 88
2018-05-15 13F-HR Walleye Trading LLC 72,692 0 -100.00 286 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 6,043 6,043 0.00 18 14 -22.22
2018-05-14 13F-HR MORGAN STANLEY 7,815 23,800 204.54 31 65 109.68
2018-05-14 13F-HR Virtu Financial LLC 30,339 0 -100.00 119 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,565 0 -100.00 89 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 647,700 0 -100.00 2,545 0 -100.00
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 35,752 35,752 0.00 140 96 -31.43
2018-05-15 13F-HR VANGUARD GROUP INC 1,593,285 1,839,094 15.43 6,261 4,984 -20.40
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 0 1,104 0 3
2018-05-15 13F-HR G2 Investment Partners Management LLC 350,000 214,170 -38.81 1,376 580 -57.85
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 299,365 289,928 -3.15 1,177 786 -33.22
2018-05-14 13F-HR ZACKS INVESTMENT MANAGEMENT 0 25,451 0 69
2018-04-27 13F-HR BOURGEON CAPITAL MANAGEMENT LLC 164,019 136,338 -16.88 645 369 -42.79
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 121,200 146,643 20.99 476 397 -16.60
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 610,621 610,621 0.00 1,826 1,404 -23.11
2018-05-14 13F-HR ARIEL INVESTMENTS, LLC 2,930,417 2,583,823 -11.83 11,517 7,002 -39.20
2018-05-14 13F-HR Axa 181,303 165,303 -8.83 713 448 -37.17
2018-05-14 13F-HR Royce & Associates LLC 1,615,544 1,590,544 -1.55 6,349 4,310 -32.12
2018-05-15 13F-HR A.R.T. Advisors, LLC 35,571 72,071 102.61 139 195 40.29
2018-05-15 13F-HR GMT Capital Corp 38,180 38,180 0.00 105 103 -1.90
2018-05-15 13F-HR Weiss Asset Management LP 17,473 47
2018-05-14 13F-HR FULLER & THALER ASSET MANAGEMENT, INC. 555,100 518,300 -6.63 2,182 1,405 -35.61
2018-05-15 13F-HR WOLVERINE TRADING, LLC 14,985 0 -100.00 59 0 -100.00
2018-05-15 13F-HR Bank of New York Mellon Corp 213,219 225,435 5.73 838 611 -27.09
2018-05-09 13F-HR BlackRock Inc. 661,641 659,504 -0.32 2,600 1,787 -31.27
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 2,436 2,436 0.00 10 7 -30.00
2018-05-08 13F-HR Neuberger Berman Group LLC 2,180,445 2,143,263 -1.71 8,569 5,808 -32.22
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 1,802,724 2,129,476 18.13 7,085 5,771 -18.55
2018-05-15 13F-HR Advisor Group, Inc. 160 0 -100.00 1 0 -100.00
2018-04-18 13F-HR/A FNY Partners Fund LP 74,175 13,040 -82.42 291 35 -87.97
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 77 77 0.00 0 0
2018-05-15 13F-HR SEGALL BRYANT & HAMILL, LLC 1,707,974 1,840,967 7.79 6,712 4,989 -25.67
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 411,935 370,172 -10.14 1,618 1,002 -38.07

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

9h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

11h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Ericsson (ERIC) to Divest Field Service Business in Sweden

2018-07-12 zacks
Ericsson (ERIC - Free Report) has decided to divest its field service business in Sweden to local communication infrastructure firm, Transtema Group, for an undisclosed amount. The transaction is likely to be completed by the third quarter of 2018, subject to mandatory closing conditions and regulatory approvals. The to-be-divested unit — Ericsson Local Services AB (“LSS”) — primarily offers field services and maintenance of fixed and mobile networks in Sweden.

SeaChange International, Inc. (SEAC) CEO Ed Terino on Q1 2019 Results - Earnings Call Transcript

2018-06-07 seekingalpha
Greetings and welcome to the SeaChange International First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mary Conway, Investor Relations. (12-0)

SeaChange - Reflecting On A Bad Call

2018-04-18 seekingalpha
Strong Q4 cash generation mostly a result of lower working capital needs and one-time sales proceeds. (7-0)

SeaChange International's (SEAC) CEO Ed Terino on Q4 2018 Results - Earnings Call Transcript

2018-04-16 seekingalpha
Greetings, and welcome to the SeaChange International’s Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. As a reminder, this conference is being recorded. (12-0)

CUSIP: 811699107